CA
DGX icon

Continental Advisors’s Quest Diagnostics DGX Stock Holding History

Continental Advisors’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-15,000
Closed -$1.01M – 154
2014
Q4 		$1.01M Sell
15,000
-1,000
-6% -$63.1K 0.2% 112
2014
Q3 		$971K Sell
16,000
-7,500
-32% -$462K 0.22% 108
2014
Q2 		$1.38M Sell
23,500
-6,000
-20% -$351K 0.32% 82
2014
Q1 		$1.71M Buy
29,500
+9,000
+44% +$482K 0.44% 66
2013
Q4 		$1.1M Hold
20,500
– – 0.24% 97
2013
Q3 		$1.27M Hold
20,500
– – 0.31% 84
2013
Q2 		$1.24M Buy
+20,500
New +$1.22M 0.35% 79

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Continental Advisors's DGX Position: Q1 2015 in Review

Continental Advisors sold out of Quest Diagnostics (DGX) in Q1 2015, closing a stake of 15,000 shares — an estimated $1.01M sold.

Continental Advisors first reported a position in DGX in Q2 2013 and held it in 7 quarters. The position peaked at $1.71M in Q1 2014. 553 funds tracked by Wall St. Rank hold DGX as of Q1 2015.

  • Continental Advisors reported no remaining Quest Diagnostics position as of Q1 2015 after selling out during the quarter.
  • Continental Advisors sold 15,000 Quest Diagnostics shares in Q1 2015, an estimated $1.01M.
  • Continental Advisors first reported a position in Quest Diagnostics in Q2 2013 and held it in 7 quarters.
  • Continental Advisors's Quest Diagnostics position peaked at $1.71M in Q1 2014.
  • 553 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2015.

Based on Continental Advisors's 13F filing for Q1 2015, filed 15 May 2015.